This is a drug monograph from the BSAVA Small Animal Formulary Part A: Canine and Feline. BSAVA members should login for access to the full monograph. Non-members can join BSAVA, buy a Formulary subscription, or buy the printed edition.
Enomoto M, Mantyh PW, Murrell J, Innes JF and Lascelles BDX (2019) Anti-nerve growth factor monoclonal antibodies for control of pain in cats and dogs. Veterinary Record184, 23
Farrell M, Waibel FWA, Carrera I et al. (2025) Musculoskeletal adverse events in dogs receiving bedinvetmab (Librela). Frontiers in Veterinary Science 12, 1581490
Michels GM, Honsberger NA, Walters RR et al. (2023) A prospective, randomized, double-blind, placebo-controlled multisite, parallel-group field study in dogs with osteoarthritis conducted in the United States of America evaluating bedinvetmab, a canine anti-nerve growth factor monoclonal antibody. Veterinary Anaesthesia and Analgesia 50, 446–458
Monteiro BP, Simon A, Knesl O, Mandello K, Nederveld S, Olby NJ, Innes JF, Lascelles BDX (2025) Global pharmacovigilance reporting of the first monoclonal antibody for canine osteoarthritis: a case study with bedinvetmab (Librela). Frontiers in Veterinary Science 12, 1558222
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
